Ready-to-use dialysis fluids tested in real-world ICU study
NCT ID NCT06983509
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracked 228 critically ill patients in China who needed continuous kidney dialysis. Doctors used pre-mixed solutions instead of custom-mixed ones to see how well they worked in everyday hospital care. The goal was to gather information on filter life, blood chemistry, and ease of use, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Anzhen Hospital, Capital Medical University
Beijing, 100029, China
-
Beijing Chao-yang Hospital, Capital Medical University
Beijing, 100020, China
-
Shanghai East Hospital
Shanghai, 200120, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, 400016, China
-
The First People's Hospital of Guangzhou
Guangzhou, 510180, China
-
Xuanwu Hospital Capital Medical University
Beijing, 100053, China
-
Zhejiang Provincial People's Hospital
Hangzhou, 310014, China
-
ZhongShan Hospital Fudan University
Shanghai, 200032, China
-
Zhongnan Hospital, Wuhan University
Wuhan, 430071, China
-
Zhujiang Hospital, Southern Medical University
Guangzhou, 510280, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What does life feel like for children with a rare birth defect? a new study asks
- Kidney health may change how this drug works
- Heat wave warning: study reveals how chronic illness patients suffer in high temperatures
- Kidney function may change how diabetes drug works
- Dialysis patients wear heart monitors for a week to uncover hidden risks
- New combo therapy could protect kidneys and hearts without High-Dose statins